Bristol-Myers Squibb (BMY) News Today $47.63 +0.06 (+0.13%) Closing price 03:59 PM EasternExtended Trading$46.78 -0.85 (-1.78%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 1.3% - What's Next?Bristol-Myers Squibb (NYSE:BMY) Trading Down 1.3% - What's Next?May 7 at 3:40 PM | marketbeat.comBrevan Howard Capital Management LP Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)Brevan Howard Capital Management LP grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 289.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 142,886 shares of the biopharmaceutical company's stock after buyMay 7 at 7:17 AM | marketbeat.comBristol-Myers Squibb Q1 Earnings TranscriptMay 7 at 7:10 AM | marketbeat.com8,767 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Chapman Financial Group LLCChapman Financial Group LLC purchased a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 8,767 shares of the biopharmaceutical company's stock, valued at appMay 7 at 6:28 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by BNP ParibasBNP Paribas lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 63.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,362 shares of the biopharmaceutical company's stock afMay 7 at 5:32 AM | marketbeat.comAlTi Global Inc. Sells 160,244 Shares of Bristol-Myers Squibb (NYSE:BMY)AlTi Global Inc. decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 97.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,091 shares of the biopharmaceutical company's stock aftMay 7 at 5:05 AM | marketbeat.comWas Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?May 6 at 9:31 PM | finance.yahoo.comBristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and ...May 6 at 12:06 PM | gurufocus.comAvidity Partners Management LP Sells 48,000 Shares of Bristol-Myers Squibb (NYSE:BMY)Avidity Partners Management LP lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 18.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 215,000 shares of the biopharmaceutical company's stock after sellingMay 6 at 7:39 AM | marketbeat.com247,000 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by BLI Banque de Luxembourg InvestmentsBLI Banque de Luxembourg Investments acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 247,000 shares of the biopharmaceuticMay 6 at 5:49 AM | marketbeat.comAmeriprise Financial Inc. Grows Position in Bristol-Myers Squibb (NYSE:BMY)Ameriprise Financial Inc. grew its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 59.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,079,246 shares of the biopharmaceutical companyMay 6 at 5:41 AM | marketbeat.comFreestone Grove Partners LP Takes $875,000 Position in Bristol-Myers Squibb (NYSE:BMY)Freestone Grove Partners LP bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 15,468 shares of the biopharmaceutical company's stock, valued at approximatelyMay 6 at 4:56 AM | marketbeat.comBristol Myers to invest $40 billion in the US over 5 yearsMay 5 at 9:06 PM | msn.comBristol Myers to invest $40 billion in the US over 5 years, CEO saysMay 5 at 5:23 PM | reuters.comWas Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?May 5 at 10:36 AM | insidermonkey.comAlpha Family Trust Sells 5,840 Shares of Bristol-Myers Squibb (NYSE:BMY)Alpha Family Trust reduced its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 31.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,920 shares of the biopharmaceutical company's stock after selling 5,840 shares during tMay 5 at 7:43 AM | marketbeat.comAptus Capital Advisors LLC Has $16.24 Million Position in Bristol-Myers Squibb (NYSE:BMY)Aptus Capital Advisors LLC grew its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1,221.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 287,206 shares of the biopharmaceutical company's stock afteMay 5 at 7:14 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Axa S.A.Axa S.A. boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 79.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 2,032,194 shares of the biopharmaceutical company's stock after acquiring an additional 900,240 shares during thMay 5 at 6:22 AM | marketbeat.comAccredited Wealth Management LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)Accredited Wealth Management LLC bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 8,449 shares of the biopharmaceutical company's stock, valued at approximately $4May 5 at 6:14 AM | marketbeat.com5,636 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Advanced Portfolio Management LLCAdvanced Portfolio Management LLC purchased a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 5,636 shares of the biopharmaceutical company's stock,May 5 at 6:14 AM | marketbeat.comMercer Global Advisors Inc. ADV Sells 109,473 Shares of Bristol-Myers Squibb (NYSE:BMY)Mercer Global Advisors Inc. ADV trimmed its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 29.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 264,279 shares of the biopharmaceutical companyMay 5 at 5:36 AM | marketbeat.comAllegheny Financial Group Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Allegheny Financial Group cut its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 54.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 8,725 shares of the biopharmaceutical company's stock after selling 10,386 shares during thMay 4 at 7:54 AM | marketbeat.comCaisse DE Depot ET Placement DU Quebec Sells 1,468,081 Shares of Bristol-Myers Squibb (NYSE:BMY)Caisse DE Depot ET Placement DU Quebec lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 64.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 814,216 shares of the biopharmaceutical company's stock after selling 1,468,081 shares during tMay 4 at 5:46 AM | marketbeat.comBristol-Myers Squibb (BMY) Faces Valuation ConcernsMay 3, 2025 | gurufocus.comEquities Analysts Set Expectations for BMY FY2025 EarningsBristol-Myers Squibb (NYSE:BMY - Free Report) - Equities research analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued to clients and investors on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now forecastsMay 3, 2025 | marketbeat.comWestbourne Investments Inc. Takes Position in Bristol-Myers Squibb (NYSE:BMY)Westbourne Investments Inc. purchased a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,830 shares of the biopharmaceutical company's stock, valued aMay 3, 2025 | marketbeat.comTalon Private Wealth LLC Invests $312,000 in Bristol-Myers Squibb (NYSE:BMY)Talon Private Wealth LLC acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,512 shares of the biopharmaceutical company's stock, valued at approximatelyMay 3, 2025 | marketbeat.comComerica Bank Decreases Stake in Bristol-Myers Squibb (NYSE:BMY)Comerica Bank lessened its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 707,633 shares of the biopharmaceutical company's stock after selMay 3, 2025 | marketbeat.comVoleon Capital Management LP Takes $2.11 Million Position in Bristol-Myers Squibb (NYSE:BMY)Voleon Capital Management LP bought a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 37,313 shares of the biopharmaceutical company's stock, valued at approximatMay 3, 2025 | marketbeat.comParvin Asset Management LLC Purchases New Stake in Bristol-Myers Squibb (NYSE:BMY)Parvin Asset Management LLC purchased a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,400 shares of the biopharmaceuticMay 2, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Cuts Holdings in Bristol-Myers Squibb (NYSE:BMY)The Manufacturers Life Insurance Company lowered its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 5.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,623,370 shares of the biopharmaceutical companyMay 2, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Dark Forest Capital Management LPDark Forest Capital Management LP cut its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 71.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,700 shares of the biopharmaceuticaMay 2, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Estimate for BMY EarningsMay 2, 2025 | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Reaches New 1-Year High After Insider Buying ActivityMay 2, 2025 | americanbankingnews.comJim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia DrugMay 1, 2025 | insidermonkey.comSchonfeld Strategic Advisors LLC Buys 206,404 Shares of Bristol-Myers Squibb (NYSE:BMY)Schonfeld Strategic Advisors LLC boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 45.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 664,205 shares of the biopharmaceutical company's stMay 1, 2025 | marketbeat.comAQR Capital Management LLC Raises Holdings in Bristol-Myers Squibb (NYSE:BMY)AQR Capital Management LLC lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,006,797 shares of the biopharmaceutical company's stock after purchasing an adMay 1, 2025 | marketbeat.comFirst-Quarter GDP Halfway to Recession: Move to These Safe High-Yield Dividend Stocks NowMay 1, 2025 | 247wallst.comBeacon Pointe Advisors LLC Sells 7,300 Shares of Bristol-Myers Squibb (NYSE:BMY)Beacon Pointe Advisors LLC reduced its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 207,321 shares of the biopharmaceutical company's stock after selling 7,300 shares durMay 1, 2025 | marketbeat.comBoothbay Fund Management LLC Invests $1.50 Million in Bristol-Myers Squibb (NYSE:BMY)Boothbay Fund Management LLC acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 26,437 shares of the biopharmaceutical company's stock, valued at approximateMay 1, 2025 | marketbeat.comNebula Research & Development LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)Nebula Research & Development LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 12,527 shares of the biopharmaceutical coMay 1, 2025 | marketbeat.comCalifornia State Teachers Retirement System Decreases Stock Position in Bristol-Myers Squibb (NYSE:BMY)California State Teachers Retirement System trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,342,684 shares of the biopharmaceApril 30, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Northern Trust CorpNorthern Trust Corp increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,658,360 shares of the biopharmaceutical company's stockApril 30, 2025 | marketbeat.comPublic Employees Retirement Association of Colorado Trims Stake in Bristol-Myers Squibb (NYSE:BMY)Public Employees Retirement Association of Colorado trimmed its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 273,602 shares of the biopharmaceutical company'sApril 30, 2025 | marketbeat.comThis High-Yield Pharma Stock Looks Like an Incredible BargainApril 30, 2025 | fool.comColdstream Capital Management Inc. Has $2.05 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Coldstream Capital Management Inc. increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 24.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,287 shares of the biopharmaceutical comApril 30, 2025 | marketbeat.comSamit Hirawat Purchases 4,250 Shares of Bristol-Myers Squibb (NYSE:BMY) StockApril 30, 2025 | insidertrades.comLeerink Partnrs Has Negative Estimate for BMY Q2 EarningsBristol-Myers Squibb (NYSE:BMY - Free Report) - Stock analysts at Leerink Partnrs dropped their Q2 2025 EPS estimates for Bristol-Myers Squibb in a research report issued on Friday, April 25th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will post earningsApril 30, 2025 | marketbeat.comIs Bristol-Myers Squibb Company (BMY) the Best Long-Term Dividend Stock to Buy According to Billionaires?April 29, 2025 | msn.comDon’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet (BMY)Recent upticks in the market may disguise the ongoing risks that remain for investors; these factors point to the importance of a defensive strategy.April 29, 2025 | marketbeat.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.120.64▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼4336▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMY Stock Free BMY Stock Alerts